Article
Genotypic Analyses of the Sclerostin rs851056 and Dickkopf rs1569198 Polymorphisms in Mexican-Mestizo Postmenopausal Osteoporosis: A Case-Control Study.
Genetic testing and molecular biomarkers - 1 Mar 2021
Vazquez-Villegas Maria L, Rodriguez-Jimenez Norma A, Contreras-Haro Betsabe, Vasquez-Jimenez Jose C, Perez-Guerrero Edsaul E, Moran-Moguel Maria-Cristina, Sánchez-Rodríguez Esther N, Villagómez-Vega Alejandra, Nuño-Arana Ismael, Becerra-Alvarado Itzel N, Rubio-Arellano Edy D, Nava-Valdivia Cesar A, Ponce-Guarneros Juan M, Fajardo-Robledo Nicte S, Nava-Zavala Arnulfo H, Gonzalez-Lopez Laura, Saldaña-Cruz Ana M
Abstract excerpt
Background: The Wnt/β catenin pathway promotes bone mineralization stimulating proliferation, differentiation, and survival of osteoblasts; it also inhibits osteoclast differentiation and osteocyte activity. Sclerostin (SOST) and Dickkopf 1 (DKK1) are Wnt/β catenin pathway inhibitors. Genetic variability in the expression of SOST and DKK1 might be involved in the development of postmenopausal osteoporosis (OP)....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
